New flu vaccine contains Gulf war syndrome adjuvant | WHAT REALLY HAPPENED

New flu vaccine contains Gulf war syndrome adjuvant

Pharmaceutical giant Novartis has just rolled out a new flu vaccine, FLUAD, intended for Americans age 65 and over. And the vaccine, developed for the 2016-2017 flu season, contains a nasty surprise – squalene, the substance many say is responsible for triggering Gulf war syndrome. {Even military personnel are speaking out about what really causes Gulf war syndrome}

Gulf war syndrome, which affects returning military veterans of the Persian Gulf War, is a cascade of conditions and symptoms including fatigue, muscle pain, cognitive problems, rashes, night sweats, and other ills. Research scientist Dr. Vera Scheibner maintains that lupus, multiple sclerosis, amyotrophic lateral sclerosis, and other life-threatening diseases can also result.

Over 250,000 of the 697,000 US veterans who served in the Persian Gulf are afflicted with the condition.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA